These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17947473)

  • 1. Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy.
    Shen L; Catalano PJ; Benson AB; O'Dwyer P; Hamilton SR; Issa JP
    Clin Cancer Res; 2007 Oct; 13(20):6093-8. PubMed ID: 17947473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer.
    Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Ahn JB
    Yonsei Med J; 2018 Jul; 59(5):588-594. PubMed ID: 29869456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.
    Ogino S; Meyerhardt JA; Kawasaki T; Clark JW; Ryan DP; Kulke MH; Enzinger PC; Wolpin BM; Loda M; Fuchs CS
    Virchows Arch; 2007 May; 450(5):529-37. PubMed ID: 17372756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer.
    Kim SH; Park KH; Shin SJ; Lee KY; Kim TI; Kim NK; Rha SY; Roh JK; Ahn JB
    Cancer Res Treat; 2016 Jan; 48(1):208-15. PubMed ID: 25943321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma.
    Sinn DH; Kim YH; Lee EJ; Ko YH; Kim KM
    Mod Pathol; 2009 Feb; 22(2):314-20. PubMed ID: 19060847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma.
    An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas.
    Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS
    Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.
    Cohen SA; Wu C; Yu M; Gourgioti G; Wirtz R; Raptou G; Gkakou C; Kotoula V; Pentheroudakis G; Papaxoinis G; Karavasilis V; Pectasides D; Kalogeras KT; Fountzilas G; Grady WM
    Clin Colorectal Cancer; 2016 Jun; 15(2):164-9. PubMed ID: 26702772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
    Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
    Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
    Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
    Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive value of CpG island methylator phenotype in patients with locally advanced nonmetastatic sporadic colorectal cancer.
    Wang Y; Long Y; Xu Y; Guan Z; Lian P; Peng J; Cai S; Cai G
    Gastroenterol Res Pract; 2014; 2014():436985. PubMed ID: 24822060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.
    Jover R; Nguyen TP; Pérez-Carbonell L; Zapater P; Payá A; Alenda C; Rojas E; Cubiella J; Balaguer F; Morillas JD; Clofent J; Bujanda L; Reñé JM; Bessa X; Xicola RM; Nicolás-Pérez D; Castells A; Andreu M; Llor X; Boland CR; Goel A
    Gastroenterology; 2011 Apr; 140(4):1174-81. PubMed ID: 21185836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample.
    Nosho K; Irahara N; Shima K; Kure S; Kirkner GJ; Schernhammer ES; Hazra A; Hunter DJ; Quackenbush J; Spiegelman D; Giovannucci EL; Fuchs CS; Ogino S
    PLoS One; 2008; 3(11):e3698. PubMed ID: 19002263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordant CpG island methylation in hyperplastic polyposis.
    Chan AO; Issa JP; Morris JS; Hamilton SR; Rashid A
    Am J Pathol; 2002 Feb; 160(2):529-36. PubMed ID: 11839573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.
    Van Rijnsoever M; Elsaleh H; Joseph D; McCaul K; Iacopetta B
    Clin Cancer Res; 2003 Aug; 9(8):2898-903. PubMed ID: 12912934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma.
    Ogi K; Toyota M; Ohe-Toyota M; Tanaka N; Noguchi M; Sonoda T; Kohama G; Tokino T
    Clin Cancer Res; 2002 Oct; 8(10):3164-71. PubMed ID: 12374684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island methylator phenotype and prognosis of colorectal cancer in Northeast China.
    Li X; Hu F; Wang Y; Yao X; Zhang Z; Wang F; Sun G; Cui BB; Dong X; Zhao Y
    Biomed Res Int; 2014; 2014():236361. PubMed ID: 25243122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer.
    Han SW; Lee HJ; Bae JM; Cho NY; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Jeong SY; Park KJ; Park JG; Kang GH; Kim TY
    Int J Cancer; 2013 May; 132(9):2209-16. PubMed ID: 23034738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long interspersed nuclear element-1 hypomethylation is a potential biomarker for the prediction of response to oral fluoropyrimidines in microsatellite stable and CpG island methylator phenotype-negative colorectal cancer.
    Kawakami K; Matsunoki A; Kaneko M; Saito K; Watanabe G; Minamoto T
    Cancer Sci; 2011 Jan; 102(1):166-74. PubMed ID: 21087350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.